Citations
323 citation(s) found for "Kaufmann, Scott H".
Faculty Opinions recommendation of SUMO-Targeted DNA Translocase Rrp2 Protects the Genome from Top2-Induced DNA Damage.
Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Optimization of liposomal topotecan for use in treating neuroblastoma.
Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Topoisomerase inhibitors and targeted delivery in cancer therapy.
Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study.
Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study.
Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma.
Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.
Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of The essential kinase ATR: ensuring faithful duplication of a challenging genome.
Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan.
Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan.
Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available